Cargando…
Self-buffering capacity of a human sulfatase for central nervous system delivery
Direct delivery of therapeutic enzymes to the Central Nervous System requires stringent formulation design. Not only should the formulation design consider the delicate balance of existing ions, proteins, and osmolality in the cerebrospinal fluid, it must also provide long term efficacy and stabilit...
Autores principales: | Wen, Yi, Salamat-Miller, Nazila, Jain, Keethkumar, Taylor, Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991414/ https://www.ncbi.nlm.nih.gov/pubmed/33762621 http://dx.doi.org/10.1038/s41598-021-86178-2 |
Ejemplares similares
-
Freeze–thaw characterization process to minimize aggregation and enable drug product manufacturing of protein based therapeutics
por: Jain, Keethkumar, et al.
Publicado: (2021) -
Self-association of human beta-galactocerebrosidase: Dependence on pH, salt, and surfactant
por: Lee, Eunhee, et al.
Publicado: (2019) -
Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
por: DeVos, Sarah L., et al.
Publicado: (2013) -
Sulfatase 1 and sulfatase 2 as novel regulators of macrophage antigen presentation and phagocytosis
por: Kim, Hyun-Je, et al.
Publicado: (2021) -
Dynamic Buffer Capacity in Acid–Base
Systems
por: Michałowska-Kaczmarczyk, Anna M., et al.
Publicado: (2015)